Dimitris Voliotis

CIK: 0001807910

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RADX

Radiopharm Theranostics Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

RADX
Radiopharm Theranostics Ltd
Oct 19, 2026
Award(A)
Option (Right to buy)
Direct
10.3M shares-
RADX
Radiopharm Theranostics Ltd
Oct 19, 2026
Award(A)
Option (Right to buy)
Direct
10.3M shares-
RADX
Radiopharm Theranostics Ltd
Oct 19, 2026
Award(A)
Option (Right to buy)
Direct
10.3M shares-

		Type	Shares	Price		Ownership
Oct 19, 2026	RADX Radiopharm Theranostics Ltd	Award(A) Option (Right to buy)	10,295,667	-	-	Direct
Oct 19, 2026	RADX Radiopharm Theranostics Ltd	Award(A) Option (Right to buy)	10,295,667	-	-	Direct
Oct 19, 2026	RADX Radiopharm Theranostics Ltd	Award(A) Option (Right to buy)	10,295,666	-	-	Direct

1-3 of 3 transactions

About Voliotis Dimitris

Voliotis Dimitris (SEC CIK 0001807910) files insider reports with the SEC as Chief Medical Officer of Radiopharm Theranostics Ltd (RADX).

Signal8 holds 2 ownership filings by Voliotis Dimitris (1 Form 3, 1 Form 4), filed between May 6, 2026 and Oct 27, 2026. Those filings report 3 transactions, the latest on Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Voliotis Dimitris's filings is in CARLTON SOUTH, VICTORIA, NY.

Recent filings by Voliotis Dimitris

Oct 19, 2026: Grants or awards of RADX derivative securities (3 lines, Form 4, code A).

Other insiders filing for Radiopharm Theranostics Ltd (RADX)

HOPPER PAUL, Director
Donnelly Noel, Director
Turner Ian Lawrence, Director
Goodwin Bruce Michael, Director

How to read Form 4 transaction codes